Literature DB >> 2532848

P53 and oncogenes expression in psoriasis.

G Tadini1, A Cerri, L Crosti, G Cattoretti, E Berti.   

Abstract

Activity of p53, H-ras, c-myc and c-fos in psoriatic lesions was studied using monoclonal antibodies (MoAbs) performing a sensitive immunohistochemical method on frozen sections. Normal skin from surgery was used as control. Reactivity of p53, H-ras and c-myc is remarkable in psoriatic plaques but, in contrast, c-fos expression does not show differences compared to control skin. These findings led us to speculate about the importance of cellular oncogenes in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2532848

Source DB:  PubMed          Journal:  Acta Derm Venereol Suppl (Stockh)        ISSN: 0365-8341


  5 in total

1.  Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue.

Authors:  T Rème; A Travaglio; E Gueydon; L Adla; C Jorgensen; J Sany
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

2.  Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue.

Authors:  P L Porter; A M Gown; S G Kramp; M D Coltrera
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

3.  Role of LIM kinases in normal and psoriatic human epidermis.

Authors:  Masaru Honma; Salvador Aznar Benitah; Fiona M Watt
Journal:  Mol Biol Cell       Date:  2006-02-08       Impact factor: 4.138

4.  Apoptosis and clinical severity in patients with psoriasis and HCV infection.

Authors:  Sami A Gabr; Mohamed Y Berika; Ahmad H Alghadir
Journal:  Indian J Dermatol       Date:  2014-05       Impact factor: 1.494

5.  Stress-Related Regulation Is Abnormal in the Psoriatic Uninvolved Skin.

Authors:  Renáta Bozó; Judit Danis; Lili Borbála Flink; Dániel László Vidács; Lajos Kemény; Zsuzsanna Bata-Csörgő
Journal:  Life (Basel)       Date:  2021-06-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.